![]() |
市場調查報告書
商品編碼
1961421
CBD寵物市場-全球產業規模、佔有率、趨勢、機會和預測:按動物類型、適應症、分銷管道、地區和競爭格局分類,2021-2031年CBD Pet Market - Global Industry Size, Share, Trends, Opportunity and Forecast, Segmented By Animal Type, By Indication, By Distribution Channel, By Region & Competition, 2021-2031F |
||||||
全球 CBD 寵物市場預計將從 2025 年的 2.5648 億美元大幅成長至 2031 年的 5.0652 億美元,複合年成長率為 12.01%。
此市場領域涵蓋了以大麻為原料的CBD產品(外用溶液、咀嚼片、油劑等),旨在緩解寵物的發炎、疼痛和焦慮。推動該行業發展的關鍵因素包括寵物日益人性化以及消費者從傳統藥物轉向天然、整體健康療法。這種轉變得益於CBD產品良好的安全性。根據美國國家動物營養補充品委員會(NASC)2024年的數據,CBD產品的不利事件發生率僅為每百萬劑2.1例,這進一步增強了消費者對這些療法的信心。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 2.5648億美元 |
| 市場規模:2031年 | 5.0652億美元 |
| 複合年成長率:2026-2031年 | 12.01% |
| 成長最快的細分市場 | 狗 |
| 最大的市場 | 北美洲 |
儘管市場有所成長,但監管的不確定性仍是市場擴張的主要障礙。 CBD作為獸用飼料添加劑尚未獲得聯邦政府核准,且缺乏統一的法律框架,這造成了合規負擔,並阻礙了獸醫專業人員正式開立此類產品處方。這種缺乏標準化的情況使州際貿易複雜化,並限制了大型零售商全面採用此類產品的能力。因此,由於這些持續存在的監管複雜性,該行業在獲得更廣泛的商業性認可方面面臨挑戰。
寵物人性化和優質化的趨勢日益加速,正成為全球CBD寵物市場的主要驅動力,從根本上改變了消費者的購買習慣。隨著飼主越來越將寵物視為家庭成員,也越來越願意投資符合人類健康趨勢的高品質、健康型產品。根據福布斯顧問公司2025年10月的調查,51%的寵物主人認為他們的寵物是重要的家庭成員,與人類同等重要。這種強烈的情感紐帶正在推動對高階護理產品的需求,並顯著增強該行業的經濟實力。美國寵物產品協會於2025年3月發布的《2025年產業趨勢報告》數據顯示,2024年美國寵物產業的總支出達到1,520億美元,凸顯了飼主與其寵物之間紐帶所創造的巨大經濟規模,這也為CBD品牌將其產品定位為健康必需品奠定了基礎。
同時,寵物慢性病和老齡化相關疾病的增加直接推動了人們對自然療法的接受度。飼主正在積極尋求傳統藥物以外的整體療法來應對行為壓力和運動功能障礙等問題,而這些正是大麻二酚(CBD)的主要用途。根據美國寵物用品協會於2024年8月發布的《2024年犬貓報告》,自2018年以來,犬類鎮靜劑的使用量激增了168%。這一成長表明消費者對緩解焦慮解決方案的偏好發生了明顯轉變,這直接有利於旨在減輕壓力的CBD配方。隨著對功能性疼痛和焦慮管理的需求不斷成長,CBD注入的零食和精油市場也持續擴張,以滿足這些治療需求。
監管的不確定性是全球CBD寵物市場商業性擴張的主要障礙。 CBD尚未被聯邦政府核准為飼料添加劑,這造成了巨大的法律責任風險,使得大型全國性零售商對銷售此類產品猶豫不決。這種被排除在高流量銷售管道之外的情況,限制了CBD產品在分散的線上和專賣市場的銷售,導致消費者認知度和購買管道有限。此外,由於缺乏聯邦監管,獸醫專業人員無法推薦此類療法,從而有效地切斷了醫療建議與產品應用之間的關鍵聯繫。
儘管消費者需求顯而易見,但市場成熟仍面臨諸多限制因素。美國寵物用品協會 (APPA) 2024 年的報告顯示,CBD 產品擁有穩固的基本客群,12% 的狗飼主會為他們的寵物使用 CBD 產品。然而,持續存在的法律不確定性仍然是限制市場發展的瓶頸,阻礙了該行業利用這一需求實現大規模應用。如果沒有一個標準化的法規結構來保障安全性和合法性,該產業就無法透過融入主流零售市場來充分釋放其成長潛力。
乳化技術的應用正在改變產品功效,解決了傳統脂質基大麻素生物利用度低的問題。製造商正積極採用這種先進的加工方法,將CBD油分解成細小顆粒,顯著增加寵物消化道的吸收面積。這項創新使得水溶性配方成為可能,與傳統酊劑相比,確保了更穩定的治療效果和更快的起效速度。在2024年4月發表於《獸醫學前沿》(Frontiers in Veterinary Science)的一項題為「四種大麻二酚製劑在犬單次口服給藥後的藥代動力學行為」的研究中,奈米乳化製劑在3小時內即可達到92至314 μg/L的血漿峰濃度,顯示其吸收速度優於其他方式。
同時,市場正經歷透過策略性收購進行的整合階段,這表明成熟的動物保健公司和投資機構正在進入該領域。這一趨勢凸顯了市場正從分散的小規模企業向成熟的環境轉變,資本投資推動了擴充性和分銷。大型公司正在收購成功的營養補充品品牌,以實現產品組合多元化,並利用這些細分市場參與者建立的良好信譽。正如《寵物食品行業》雜誌在2024年12月報導的那樣,“預計2025年寵物行業的併購活動將激增”,私募股權投資者在11月下旬收購寵物營養補充劑公司FoodScience,正是該行業金融發展的一個象徵性例證,也表明機構投資者對高質量營養相關資產的興趣日益濃厚。
The Global CBD Pet Market is projected to expand significantly, growing from USD 256.48 Million in 2025 to USD 506.52 Million by 2031, reflecting a compound annual growth rate of 12.01%. This market sector includes hemp-derived cannabidiol products, such as topicals, chews, and oils, developed to relieve inflammation, pain, and anxiety in companion animals. Key drivers propelling this industry include the increasing humanization of pets and a consumer shift toward natural, holistic health alternatives rather than traditional pharmaceuticals. This transition is supported by strong safety records; according to 2024 data from the National Animal Supplement Council, adverse events for CBD products occurred at a rate of only 2.1 per one million administrations, reinforcing consumer trust in these therapies.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 256.48 Million |
| Market Size 2031 | USD 506.52 Million |
| CAGR 2026-2031 | 12.01% |
| Fastest Growing Segment | Dogs |
| Largest Market | North America |
Despite this growth, regulatory uncertainty remains a significant barrier to wider market development. The lack of federal approval for CBD as a veterinary feed additive and inconsistent legal frameworks create compliance burdens that prevent veterinary professionals from officially prescribing these products. This absence of standardization complicates interstate trade and limits the ability of major retailers to fully adopt the category. Consequently, the industry faces challenges in achieving broader commercial acceptance due to these ongoing regulatory complexities.
Market Driver
The escalating trend of pet humanization and premiumization acts as a primary driver for the Global CBD Pet Market, fundamentally reshaping consumer purchasing habits. As owners increasingly regard their pets as essential family members, there is a greater willingness to invest in high-quality, wellness-oriented products that align with human health trends. According to Forbes Advisor in October 2025, 51% of pet owners consider their animals to be as integral to the family as human members. This strong emotional connection fuels the demand for premium care options, contributing substantially to the industry's financial strength. Data from the American Pet Products Association's '2025 State of the Industry Report', released in March 2025, indicates that total U.S. pet industry spending reached $152 billion in 2024, highlighting the vast economic scale of the owner-pet bond that CBD brands are leveraging to position their products as wellness necessities.
Concurrently, the rising prevalence of chronic and age-related ailments in pets provides a direct pathway for the adoption of natural remedies. Owners are actively seeking holistic substitutes for conventional pharmaceuticals to manage issues like behavioral stress and mobility problems, which are primary use cases for cannabidiol. The American Pet Products Association reported in its '2024 Dog and Cat Report' from August 2024 that the usage of calming products for dogs has surged by 168% since 2018. This increase underscores a distinct consumer pivot toward anxiety-relief solutions, directly benefiting CBD formulations designed to mitigate stress. As the demand for functional pain and anxiety management grows, the market for CBD-infused treats and oils continues to expand to meet these therapeutic needs.
Market Challenge
Regulatory ambiguity acts as a major hurdle restricting the commercial scalability of the global CBD pet market. The lack of federal designation for CBD as an approved feed additive creates significant liability risks, discouraging major national retailers from stocking these products. This exclusion from high-traffic sales channels forces distribution into fragmented online and specialty markets, thereby limiting consumer visibility and accessibility. Furthermore, the absence of federal oversight prevents veterinary professionals from endorsing these therapies, effectively severing the critical connection between medical advice and product adoption.
This restriction on market maturation persists despite clear evidence of consumer demand. In 2024, the American Pet Products Association reported that 12% of dog owners utilized CBD products for their pets, demonstrating a viable customer base. However, continued legal uncertainty functions as a bottleneck, preventing the sector from capitalizing on this interest to achieve mass adoption. Without a standardized regulatory framework to assure safety and legality, the industry remains unable to unlock its full growth potential through integration into mainstream retail markets.
Market Trends
The adoption of nano-emulsion technology is transforming product efficacy by addressing the naturally low bioavailability associated with traditional lipid-based cannabinoids. Manufacturers are increasingly using this advanced processing method to break down CBD oil into microscopic particles, significantly increasing the surface area for absorption within a pet's digestive tract. This innovation enables water-soluble formulations that ensure more consistent therapeutic outcomes and faster onset times compared to conventional tinctures. A study published in Frontiers in Veterinary Science in April 2024, titled 'Pharmacokinetics behavior of four cannabidiol preparations following single oral administration in dogs', revealed that nano-emulsion based formulations achieved maximum plasma concentrations in the range of 92-314 μg/L within three hours, outperforming other delivery methods in rapid absorption.
Simultaneously, the market is undergoing a phase of consolidation through strategic acquisitions, signaling the entry of established animal health and equity firms into the space. This trend highlights a shift from fragmented, small-scale operations toward a matured landscape where capital investment drives scalability and distribution reach. Large entities are acquiring successful supplement brands to diversify portfolios and capitalize on the established trust these niche players have built. As noted by Petfood Industry in December 2024 regarding 'Pet industry M&As set to surge in 2025', the sector's financial evolution was exemplified by the acquisition of FoodScience pet supplements by private equity investors in late November, illustrating the heightened institutional interest in high-quality nutritional assets.
Report Scope
In this report, the Global CBD Pet Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global CBD Pet Market.
Global CBD Pet Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: